Search research articles
Contact Us
Filters
Showing results (81-90 of 219) with videos related to
Page
of 22
Sort By:
Transplantation Proceedings
|
April 6, 2005
A microparticle enzyme immunoassay to measure sirolimus
D W Holt, M Moreton, K Laamanen, et al.
British Heart Journal
|
April 1, 1985
Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage
D P Nicholls, J G Murtagh, D W Holt
Therapeutic Drug Monitoring
|
May 14, 2013
CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients
N Spierings, D W Holt, Iain A M MacPhee
British Journal of Clinical Practice. Supplement
|
April 1, 1986
Hepatic effects of amiodarone
P C Adams, M K Bennett, D W Holt
Human Toxicology
|
May 1, 1987
Cardiac glycoside toxicity resulting from cough linctus abuse
A B Mason, S E Pugh, D W Holt
Biomedical Chromatography : BMC
|
January 1, 1987
HPLC measurement of diltiazem and desacetyldiltiazem in serum or plasma
R K Bhamra, A E Ward, D W Holt
Drug Safety
|
December 1, 1993
Class III antiarrhythmics in overdose. Presenting features and management principles
E W Leatham, D W Holt, W J McKenna
Lancet (London, England)
|
October 23, 1982
Lack of response to intravenous calcium in severe verapamil poisoning
B J Crump, D W Holt, J A Vale
Journal of Chromatography
|
October 26, 1990
High-performance liquid chromatographic method for the measurement of buflomedil in plasma and serum
R J Eastwood, R K Bhamra, D W Holt
British Journal of Clinical Pharmacology
|
June 1, 1977
Digoxin measurements in general practice
D W Holt, J D Williamson, G N Volans
Page
of 22
Search research articles
Search
Showing results (81-90 of 219) with videos related to
Sort By:
Page
of 22
Transplantation Proceedings
|
April 6, 2005
A microparticle enzyme immunoassay to measure sirolimus
D W Holt, M Moreton, K Laamanen, et al.
British Heart Journal
|
April 1, 1985
Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage
D P Nicholls, J G Murtagh, D W Holt
Therapeutic Drug Monitoring
|
May 14, 2013
CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients
N Spierings, D W Holt, Iain A M MacPhee
British Journal of Clinical Practice. Supplement
|
April 1, 1986
Hepatic effects of amiodarone
P C Adams, M K Bennett, D W Holt
Human Toxicology
|
May 1, 1987
Cardiac glycoside toxicity resulting from cough linctus abuse
A B Mason, S E Pugh, D W Holt
Biomedical Chromatography : BMC
|
January 1, 1987
HPLC measurement of diltiazem and desacetyldiltiazem in serum or plasma
R K Bhamra, A E Ward, D W Holt
Drug Safety
|
December 1, 1993
Class III antiarrhythmics in overdose. Presenting features and management principles
E W Leatham, D W Holt, W J McKenna
Lancet (London, England)
|
October 23, 1982
Lack of response to intravenous calcium in severe verapamil poisoning
B J Crump, D W Holt, J A Vale
Journal of Chromatography
|
October 26, 1990
High-performance liquid chromatographic method for the measurement of buflomedil in plasma and serum
R J Eastwood, R K Bhamra, D W Holt
British Journal of Clinical Pharmacology
|
June 1, 1977
Digoxin measurements in general practice
D W Holt, J D Williamson, G N Volans
Page
of 22